Reviewed by Laurence P. Banville, Esq.Frequently asked questions
What injuries are linked to liraglutide lawsuits?
Liraglutide (sold as Victoza and Saxenda) has been linked to acute pancreatitis, pancreatic cancer, thyroid tumors (including medullary thyroid carcinoma), and gallbladder disease. Plaintiffs allege manufacturers failed to adequately warn patients and prescribing physicians about these risks despite internal safety data.
Can I file a liraglutide lawsuit in New York?
Yes. New York residents harmed by liraglutide can pursue product liability claims against manufacturers like Novo Nordisk under theories of failure to warn, defective design, or negligence. Under CPLR §214, you generally have three years from the date of injury — or from when you reasonably discovered the connection — to file suit.
What compensation can liraglutide lawsuit victims recover in NY?
Victims may seek damages for medical expenses, lost wages, pain and suffering, and long-term disability. New York does not cap compensatory damages in personal injury cases, so recoverable amounts depend on the severity of harm, the strength of evidence, and the specific facts of each case. No outcome is guaranteed.
How do I start a liraglutide lawsuit in New York?
Preserve all medical records, prescription history, and documentation of your diagnosis. Contact a NY personal injury attorney as soon as possible — the 3-year SOL under CPLR §214 begins running from the date of injury or discovery. An attorney can evaluate whether your case qualifies for individual litigation or joinder in a mass tort proceeding.